Stage IA Pancreatic Cancer AJCC v8
5 clinical trials · Condition
◉ Watch Stage IA Pancreatic Cancer AJCC v8
| Record | Firm | Date |
|---|---|---|
| Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer (NCT04940286) | M.D. Anderson Cancer Center | 2021-09-28 |
| A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer (NCT05055323) | Thomas Jefferson University | 2021-07-29 |
| A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma (NCT04111172) | Thomas Jefferson University | 2020-11-10 |
| Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer (NCT04400903) | OHSU Knight Cancer Institute | 2020-09-21 |
Track Stage IA Pancreatic Cancer AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.